GLP-1 users are defined as patients with an approved claim for at least one of the following GLP-1 medications in the prior 12 months: Mounjaro, Ozempic, Rybelsus, Saxenda, Wegovy, and Zepbound
This integration enables employees and their families to better understand, navigate, and pay for healthcare, while also providing employers with valuable insights to control costs and improve health outcomes
However, researchers did not find an association between changes in taste perception and BMI reduction
No tirzepatide drops or oral semaglutide drops
Unregulated compounds and dosing mistakes Compounded GLP-1 drugs prescribed during previous shortages continue to be another issue, Jaworski said
Researchers who are studying the impact of GLP-1 agonists in addiction are hopeful